Central serous chorioretinopathy: what we have learnt so far

Area of Science:

• Ophthalmology
• Retinal Diseases
• Medical Imaging

Background:

• Central serous chorioretinopathy (CSCR) is a frequent cause of visual impairment.
• Current management includes observation, photodynamic therapy (PDT), and laser procedures.
• Recent years have seen significant progress in CSCR diagnostics and therapeutics.

Purpose of the Study:

• To review and update the management strategies for CSCR.
• To evaluate recent advancements in imaging, functional testing, and treatment modalities.
• To determine the optimal current treatment for CSCR based on existing evidence.

Main Methods:

• Literature review of studies primarily from the past decade.
• Analysis of risk factor modifications, pharmacological interventions, PDT, and laser procedures.
• Comparison of efficacy for different treatment approaches in acute and chronic CSCR.

Main Results:

• Photodynamic therapy (PDT) has seen advancements with adjusted parameters, offering greater insights into its efficacy.
• Novel laser procedures, like the diode micropulse laser, demonstrate comparable results to conventional lasers with reduced damage.
• Antivascular endothelial growth factor and mineralocorticoid receptor antagonists are emerging as potentially effective treatments.

Conclusions:

• Photodynamic therapy (PDT) remains the current best option for managing Central serous chorioretinopathy (CSCR).
• Continued research into novel treatments and understanding of pathogenesis is crucial.
• Personalized management strategies considering risk factors are essential for optimal outcomes.